Paul B Manning is Director of Verrica Pharmaceuticals Inc.. Currently has a direct ownership of 7.85 Million shares of VRCA, which is worth approximately $62.4 Million. The most recent transaction as insider was on Jul 24, 2023, when has been sold 200,000 shares (Common Stock) at a price of $5.02 per share, resulting in proceeds of $1,003,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.85M
0% 3M change
0% 12M change
Total Value Held $62.4 Million

Paul B Manning Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 24 2023
BUY
Open market or private purchase
$1,003,999 $5.02 p/Share
200,000 Added 2.48%
7,851,128 Common Stock
Jul 05 2022
BUY
Open market or private purchase
$9,999,998 $2.1 p/Share
4,761,904 Added 25.86%
13,651,128 Common Stock
Dec 03 2021
BUY
Open market or private purchase
$184,188 $9.22 p/Share
19,977 Added 0.24%
8,149,394 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$283,717 $9.45 p/Share
30,023 Added 0.37%
8,129,417 Common Stock

Also insider at

TSHA
Taysha Gene Therapies, Inc. Healthcare
LQDA
Liquidia Corp Healthcare
ABOS
Acumen Pharmaceuticals, Inc. Healthcare
CADL
Candel Therapeutics, Inc. Healthcare
PBM

Paul B Manning

Director
Charlottesville, VA

Track Institutional and Insider Activities on VRCA

Follow Verrica Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRCA shares.

Notify only if

Insider Trading

Get notified when an Verrica Pharmaceuticals Inc. insider buys or sells VRCA shares.

Notify only if

News

Receive news related to Verrica Pharmaceuticals Inc.

Track Activities on VRCA